Local

Cambridge Company Raises $5M In Quest To Discover Drug To Treat Parkinson’s

View Comments
(Credit: iStock Image)

(Credit: iStock Image)

420x316-grad-silva Anthony Silva
Anthony Silva is co-host of the WBZ Afternoon News heard each wee...
Read More

CBS Boston (con't)

Affordable Care Act Updates: CBSBoston.com/ACA

Health News & Information: CBSBoston.com/Health

CAMBRIDGE (CBS) — A Cambridge medical research and development company has raised $5 million to finance its journey to try to discover the first drug that can treat Parkinson’s Disease.

Lysosomal Therapeutics attracted investments from some of the biggest names in the business such as Sanofi-Genzyme, Roche and Partners.

CEO Case Bean tells WBZ NewsRadio 1030’s New England Business Editor Anthony Silva, research is based on work done early at Massachusetts General Hospital.

WBZ’s New England Business Editor Anthony Silva reports

 

WBZ NewsRadio 1030

WBZ NewsRadio 1030

 

Bean says this is a very exciting area of research that will develop small molecules to treat the underlying cause.

Lysosomal Therapeutics was launched by former Genzyme executives, including CEO Henri Termeer.

MORE LOCAL NEWS FROM CBS BOSTON

 

View Comments
blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 2,704 other followers